Clinical and molecular aspects of retinoid therapy for acute promyelocytic leukemia

International Journal of Cancer

Volumn 70, Issue 4, 1997, Pages 496-497

  Warrell Jr , Raymond P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; RETINOID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; POLYMERASE CHAIN REACTION; REMISSION INDUCTION; TRETINOIN;

EID: 1842333274     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970207)70:4<496::AID-IJC25>3.0.CO;2-C     Document Type: Article

References (12)

1. DE THÉ, H., CHOMIENNE, C., LANOTTE, M., DEGOS, L. and DEJEAN, A., The t(15;17) translocation of acute promyelocytic leukemia fuses retinoic acid receptor alpha gene to a novel transcribed locus. Nature (Lond.), 347, 558-561 (1990).
2. FENAUX, P., CASTAIGNE, S., DOMBRET, H., ARCHIMBAUD, E., DUARTE, M., MOREL, P., LANY, T., TILLY, H., GUERCI, A. and MALOISEL, F., All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood, 80, 2176-2181 (1992).
3. PENAUX, P., LEDELY, M.C., CASTAIGNE, S., ARCHIMBAUD, E., CHOMIENNE, C., LINK, H., GUERCI, A., DUARTE, M., DANIEL, M.T. and BONEN, D., Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicenter randomized trial. Blood. 82, 3241-3249 (1993).
4. FRANKEL, S.R., EARDLY, A., LAUWERS, G., WEISS, M. and WARRELL, R.P., JR., The retinoic acid syndrome in acute promyelocytic leukemia. Ann. intern. Med., 117, 292-296 (1992).
5. HUANG, M.E., YE, Y.C., CHEN, S.R., CHAI, J.R., LA, J.X., GU, L.J. and WANG, Z.Y., Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572 (1988).
6. LO COCO, F., AVVISATI, G., DIVERIO, D., PETTI, M.C., ALCALAY, M., PANDOLFI, P.P., ZANGRILLI, D., BIONDI, A., RAMBALDI, A., MOLETI, M.L., MANDELLI, F. and PELICCI, P.G., Molecular evaluation of response to all-trans retinoic acid therapy in patients with acute promyelocytic leukemia. Blood, 77, 1657-1659 (1991).
7. MILLER, W.H., JR., LEVINE, K., DEBLASIO, A., FRANKEL, S.R., DMITROVSKY, E. and WARRELL, R.P., JR., Detection of minimal residual disease in acute promyelocytic leukemia by reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA. Blood. 82, 1689-1694 (1993).
8. TALLMAN, M.S., ANDERSEN, J. and SCHIFFER, C.A., Phase III randomized study of all-trans retinoic acid (ATRA) vs. daunorubicin (D) and cytosine arabinoside (A) as induction therapy and ATRA vs. observation as maintenance therapy for patients with previously untreated acute promyelocytic leukemia (APL). Blood (Suppl.), 86, 125a (1995).
9. WARRELL, R.P., JR., DE THÉ, H., WANG, Z.-Y. and DEGOS, L., Acute promyelocytic leukemia. New Engl. J. Med., 329, 177-189 (1993).
10. WARRELL, R.P., JR., MASLAK, P., EARDLEY, A., HELLER, G., MILLER, W.H. and FRANKEL, S.R., Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Leukemia, 8, 929-933 (1994).
11. WEIS, K., RAMBAUD, S., LAVAU, C., JANSEN, J., CARVALKO, T., CARMO-FONSECA, M., LAMOND, A. and DEJEAN, A., Retinoic acid regulates aberrant nuclear localization of PML-RAR-alpha in acute promyelocytic leukemia cells. Cell, 76, 345-356 (1994).
12. YOSHIDA, H., KITAMURA, K. and TANAKA, K., Accelerated degradation of PML-retinoic acid receptor-alpha (PML-RARA) oncoprotein by all-trans retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res., 56, 2945-2948 (1996).